Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for a Phase 3 deucravacitinib trial in psoriatic arthritis is available, with its design, eligibility requirements, outcome measures, locations, and supporting documents. The record also includes results and information about sharing anonymized participant data.
    Difference
    100%
    Check dated 2026-11-08T07:10:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T07:52:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov navigation, linking to transition updates and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T06:58:18.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:30:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:11:17.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Updated page to Revision: v3.7.0. Sponsor branding and links to study documents, IPD sharing information, and related resources were removed from the study record.
    Difference
    19%
    Check dated 2026-09-20T03:22:55.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.